Skip to content
zameds

Ammonium chloride, codeine, diphenhydramine, sodium citrate

Sold as Tussilinct, Tussitot, Broncleer with codeine cough

Combination product

This product contains more than one active ingredient, so it has no single molecular structure.

Background

Loading...
Loading Wikipedia summary

Registration

Applicants
2
Registrations
3

Applicants and registrations

ApplicantBrandsDosagesRegistrationsScheduleLeaflets
The Premier Pharmaceutical Co LtdTussilinct, TussitotsyrupG0998, G0999Not determinedNone
Adcock ingram limitedBroncleer with codeine coughsyrupG1112Not determinedNone

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Tussilinct

10 ML AMMONIUM CHLORIDE A 274 MG CODEINE PHOSPHATE A 10,0 MG DIPHENHYDRAMINE HYDROCHLORIDE A 28,0 MG SODIUM CITRATE A 112 MG

Not listedG0998Old MedicineNot determinedNone
Tussitot syrup

5 ML AMMONIUM CHLORIDE A 68,5 MG CODEINE PHOSPHATE A 2,5 MG DIPHENHYDRAMINE HYDROCHLORIDE A 7 MG SODIUM CITRATE A 28,0 MG

SyrupG0999Old MedicineNot determinedNone
Broncleer with codeine cough syrup

EACH 5,0 ml CONTAINS AMMONIUM CHLORIDE 125,0 mg CODEINE PHOSPHATE 10,0 mg DIPHENHYDRAMINE HYDROCHLORIDE 12,5 mg SODIUM CITRATE 50,0 mg

SyrupG1112G/10.1/1112RegisteredNot determinedNone

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

SAHPRA documents

SAHPRA has not published a professional information or patient information leaflet for this product.

Research articles

Loading...
Loading PubMed articles